CLASS II ONGOING Device recall · Reported 11 Oct 2023 · FDA Enforcement Report

Bard Marquee Disposable Core Biopsy Instrument Kit recalled

Bard Peripheral Vascular is recalling Bard Marquee Disposable Core Biopsy Instrument Kit, distributed nationwide in the US. The recall was initiated on 10 Aug 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 00801741097393, Lot: 0001480774, Exp: 07/28/2025
Quantity recalled1,545

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0027-2024
FDA event ID
92994
Recalling firm
Bard Peripheral Vascular, Tempe, AZ
Classification
Class II
Status
Ongoing
Recall initiated
10 Aug 2023
FDA classified
4 Oct 2023
Reported
11 Oct 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

10 Aug 2023Recall initiated by company
4 Oct 2023Classified by FDA+55 days
11 Oct 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Diameter mismatch between coaxial and biopsy needle (cutting cannula) in disposable core biopsy instrument kits, where the coaxial cannula inner diameter prohibits the biopsy needle (cutting cannula) from properly fitting into the coaxial cannula and accessing target tissue, which may lead to repeated procedure, and procedural complications, such as pain/discomfort, pneumothorax, and bleeding.

Product as listed by the FDA

Bard Marquee Disposable Core Biopsy Instrument Kit, REF: MQK2016

Where it was distributed

Worldwide - US Nationwide distribution in the states of PR, CO, TX, CA, WA, OR, AZ, NJ, NY, OH, NC, MD, MI, LA, IN, AK, TN and the countries of CA, AU, BE.

Nationwide AlaskaArizonaCaliforniaColoradoIndianaLouisianaMarylandMichiganNorth CarolinaNew JerseyNew YorkOhioOregonPuerto RicoTennesseeTexasWashington

Questions about this recall

Why was it recalled?

Diameter mismatch between coaxial and biopsy needle (cutting cannula) in disposable core biopsy instrument kits, where the coaxial cannula inner diameter prohibits the biopsy needle (cutting cannula) from properly fitting into the coaxial cannula and accessing target tissue, which may lead to repeated procedure, and procedural complications, such as pain/discomfort, pneumothorax, and bleeding.

Which lots are affected?

UDI-DI: 00801741097393, Lot: 0001480774, Exp: 07/28/2025

Where was it sold?

Worldwide - US Nationwide distribution in the states of PR, CO, TX, CA, WA, OR, AZ, NJ, NY, OH, NC, MD, MI, LA, IN, AK, TN and the countries of CA, AU, BE.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bard Peripheral Vascular

All 139

Other Other Medical Devices recalls

All 13,908